Natalizumab throughout pregnancy: Risk of low platelet count in the newborn at delivery.

Rev Neurol (Paris)

Department of neurology, CHU de Poitiers, university of Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France.

Published: February 2016

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurol.2015.07.007DOI Listing

Publication Analysis

Top Keywords

natalizumab pregnancy
4
pregnancy risk
4
risk low
4
low platelet
4
platelet count
4
count newborn
4
newborn delivery
4
natalizumab
1
risk
1
low
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!